Arsenic and abdominal pain Patient Reports February 12, 2012

Arsenic Side Effects Report #5203795-2
Arsenic side effect was reported by a Physician from UNITED STATES on Dec 22, 2006. Female patient, 62 years of age, weighting 166.2 lb, was diagnosed with myelofibrosis and was treated with Arsenic. After drug was administered, patient experienced the following side effects: abdominal pain , haemorrhage, infarction, splenomegaly. Arsenic dosage: 19 MG TWICE WEEKLY INTRAVENOUS DRIP. During the same period patient was treated with THALIDOMIDE, ASCORBIC ACID, DECADRON, MAGNESIUM OXIDE, POTASSIUM CHLORIDE, DAPSONE, COMBIVENT, ALBUTEROL. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5218705-1
Arsenic side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2007. Female patient, 62 years of age, weighting 166.2 lb, was diagnosed with myelofibrosis and was treated with Arsenic. After drug was administered, patient experienced the following side effects: abdominal pain , condition aggravated, myeloproliferative disorder, splenomegaly. Arsenic dosage: 19 MG TWICE WEEKLY INTRAVENOUS DRIP. During the same period patient was treated with THALIDOMIDE, ASCORBIC ACID, DECADRON, MAGNESIUM OXIDE, POTASSIUM CHLORIDE, DAPSONE, COMBIVENT, ALBUTEROL. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4906107-4
Arsenic side effect was reported by a Health Professional from UNITED STATES on Feb 07, 2006. Female patient, 80 years of age, weighting 127.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , crepitations. Arsenic dosage: 13.2 MG TWICE WEEKLY IV. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5713663-5
Arsenic side effect was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Apr 04, 2008. Female patient, child 6 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , acute promyelocytic leukaemia differentiation syndrome, differential white blood cell count abnormal, dyspnoea, electrocardiogram qt prolonged, gastrointestinal hypomotility, haemoglobin decreased, ileus paralytic. Arsenic dosage: 0.15 MG/KG FIVE DAYS PER WEEK INTRAVENOUS. Patient recovered.